Inactive Instrument
Agile Therapeutics, Inc. Stock
Stocks
AGRX
US00847L3087
Biotechnology & Medical Research
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Robert Spina
CEO | Chief Executive Officer | - | 2024-08-25 |
| Corporate Secretary | - | 2024-08-25 |
| Director | Title | Age | Since |
|---|---|---|---|
Salustiano Pérez
CHM | Chairman | - | 2024-08-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/26/24 | Issuer sale | Director | 976 | 0.0142% | ||
| 8/26/24 | Issuer sale | Chief Administrative Officer | 20,256 | 0.2954% | ||
| 8/26/24 | Issuer sale | Chief Financial Officer | 20,080 | 0.2929% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.42% | - | - | 10.43M | |
| +2.35% | +2.74% | +38.10% | +74.02% | 56.54B | |
| -0.91% | -6.53% | +25.63% | +62.24% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -13.72% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +352.92% | 21.37B | |
| +0.15% | +0.36% | +24.28% | -14.44% | 20.27B | |
| +0.36% | -2.20% | +31.97% | -29.08% | 17.56B | |
| -1.45% | -7.15% | +17.96% | +554.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +287.77% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +160.72% | 13.33B | |
| Average | -0.13% | -3.79% | +35.35% | +159.44% | 25.98B | |
| Weighted average by Cap. | +0.01% | -2.96% | +30.18% | +120.41% |
Employees
19
